Characteristics and treatment of patients with essential thrombocythemia during the period of 2008–2011
Background: Essential thrombocythemia (ET) is a chronic Ph negative myeloproliferative neoplasm characterized by thrombocytosis, bone marrow megakaryocyte proliferation, JAK 2 V617F mutation in 50–60 % of patients and MPL mutation in 3–5 % of patients. Higher mortality of ET patients is caused by va...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Slovenian Medical Association
2012-12-01
|
| Series: | Zdravniški Vestnik |
| Online Access: | http://vestnik.szd.si/index.php/ZdravVest/article/view/745 |